|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
25 February 2013 |
|
Main ID: |
NCT00250159 |
|
Date of registration:
|
05/11/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Natural History Study of Patients With Excess Androgen
|
|
Scientific title:
|
Natural History Study of Patients With Excess Androgen |
|
Date of first enrolment:
|
October 2005 |
|
Target sample size:
|
1060 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00250159 |
|
Study type:
|
Observational |
|
Study design:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) |
|
Address:
|
|
|
Telephone:
|
800-411-1222 |
|
Email:
|
prpl@mail.cc.nih.gov |
|
Affiliation:
|
|
|
|
Name:
|
Deborah P Merke, M.D. |
|
Address:
|
|
|
Telephone:
|
(301) 496-0718 |
|
Email:
|
dmerke@mail.cc.nih.gov |
|
Affiliation:
|
|
|
|
Name:
|
Deborah P Merke, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
National Institutes of Health Clinical Center (CC) |
|
|
Key inclusion & exclusion criteria
|
- INCLUSION CRITERIA:
Males with known or suspected FMPP.
Patients with known or suspected CAH due to 21-hydroxylase deficiency, 11-hydroxylase
deficiency, or 3-beta-hydroxysteroid dehydrogenase deficiency. Classic and nonclassic
patients are eligible.
Patients with excess androgen of unknown etiology.
EXCLUSION CRITERIA:
Females with isolated polycystic ovary syndrome. If, following a diagnostic work-up, a
patient is determined to have PCOS as the only cause of her hyperandrogenism; she will no
longer be followed on this protocol.
Patients with significant nonendocrine medical conditions.
Age minimum:
N/A
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Congenital Adrenal Hyperplasia (CAH)
|
|
Excess Androgen
|
|
Familial Male-Limited Precocious Puberty (FMPP)
|
|
Secondary ID(s)
|
|
06-CH-0011
|
|
060011
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|